Prime Medicine (PRME) Deferred Taxes (2021 - 2024)

Prime Medicine (PRME) posted Deferred Taxes of -$134000.0 for Q2 2024, down 200.0% on a QoQ basis from $134000.0 in Q1 2024, and down 532.26% year-over-year from $31000.0 in Q3 2023.

Prime Medicine (PRME) Deferred Taxes (2021 - 2024) Analysis & Trends

Prime Medicine's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$134000.0 for Q2 2024.

  • Quarterly Deferred Taxes fell 532.26% year-over-year to -$134000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was -$134000.0 (down 335.09% YoY) and the FY2023 annual result came in at -$279000.0, up 71.06% from the prior year.
  • Deferred Taxes was -$134000.0 for Q2 2024 at Prime Medicine, down from $134000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $1.2 million in Q4 2021 and bottomed at -$532000.0 in Q1 2022.
  • A 4-year average of $0.0 and a median of -$121000.0 in 2023 frame the typical range for Deferred Taxes.
  • Peak annual rise in Deferred Taxes reached 166.34% in 2024, while the deepest fall reached 532.26% in 2024.
  • Prime Medicine's Deferred Taxes stood at $1.2 million in 2021, then tumbled by 116.25% to -$202000.0 in 2022, then surged by 46.53% to -$108000.0 in 2023, then dropped by 24.07% to -$134000.0 in 2024.
  • Business Quant data shows PRME's Deferred Taxes at -$134000.0 in Q2 2024, $134000.0 in Q1 2024, and -$108000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prime Medicine 525.98 Mn 525.98 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -134,000.00
Mar 31, 2024 134,000.00
Sep 30, 2023 -108,000.00
Jun 30, 2023 31,000.00
Mar 31, 2023 -202,000.00
Dec 31, 2022 -202,000.00
Sep 30, 2022 212,000.00
Jun 30, 2022 -442,000.00
Mar 31, 2022 -532,000.00
Dec 31, 2021 1.24 Mn